Oracle will buy up to 2.8 GW of Bloom Energy fuel-cell power for its AI data centers; 1.2 GW is already under contract and deployment is underway.

Clinton‑Sherman Industrial Airpark has been rebranded Infinity One as Oklahoma courts suborbital launches and Dawn Aerospace eyes Burns Flat for 2027 flights. State officials point to a 13,503‑foot runway and industrial park to sell the site to aerospace tenants.

Swedish AI startup Lovable opened a Downtown Crossing office at One Lincoln and plans to hire dozens for sales and customer roles.

Ann Arbor startup Sygaldry secured $139M to build quantum-accelerated AI servers that promise faster model training and lower energy use.

A $100 million BATWorks initiative will turn the Brooklyn Army Terminal into a climate tech testing ground, promising hundreds of local jobs and pilots ahead of a 2028 launch.

The 41st Space Symposium has filled The Broadmoor with CEOs, generals and thousands of attendees as budget fights and defense priorities take center stage.

Local pad activity, Booster 19 testing and a Starbase closure have pushed SpaceX’s next Starship flight into an early‑to‑mid‑May window. Here’s what to watch.

Khan Academy, TED and ETS are teaming up on a competency-based B.S. in applied AI with big-tech partners and a targeted price near $10K; applications are expected in 12–18 months.

The Bexar County Sheriff’s Office has started training deputies on Axon’s AI Translation Assistant, which transcribes and translates body‑cam audio in near real time. The feature is being added to existing Axon cameras and evidence software.

A bright, long‑period comet is visible in Columbus’ predawn sky this week. Here’s when to look, what gear helps and why astronomers call it a once‑in‑170,000‑years sighting.

Surgeons at UCHealth implanted a brain‑computer interface into higher cortical areas in Aurora; researchers say the move, among the first of its kind, could restore device control and sensation.

A Northwestern‑developed drug, elraglusib, doubled one‑year survival in a randomized phase 2 trial for metastatic pancreatic cancer, researchers report. The result sets up a planned phase 3.

Mass General Brigham researchers found plasma pTau217 rises years before amyloid shows on PET scans, offering a cheaper path to earlier Alzheimer's detection and trial recruitment.